Literature DB >> 29285766

Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects.

Masaru Kato1, Tatsuya Atsumi1.   

Abstract

Recent studies have clarified that pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH) has some distinctive clinical aspects from other PAH, such as high prevalence, venous and cardiac involvement, less favourable outcome, helpfulness of detection algorithm, response to immunosuppression, pre-PAH conditions in borderline pulmonary arterial pressure and coexistence of interstitial lung disease. In this review, by focusing on these distinctive aspects, we discuss how to provide an efficacious and safe management of CTD-PAH and garner attention to areas where further evidence is desired.
© 2017 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  connective tissue diseases; pulmonary arterial hypertension; pulmonary hypertension; systemic lupus erythematosus; systemic sclerosis

Mesh：

Substances：

Year:  2017        PMID： 29285766     DOI： 10.1111/eci.12876

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


  7 in total

1.  Aicardi goutières syndrome is associated with pulmonary hypertension.

Authors:  Laura A Adang; David B Frank; Ahmed Gilani; Asako Takanohashi; Nicole Ulrick; Abigail Collins; Zachary Cross; Csaba Galambos; Guy Helman; Usama Kanaan; Stephanie Keller; Dawn Simon; Omar Sherbini; Brian D Hanna; Adeline L Vanderver
Journal:  Mol Genet Metab       Date:  2018-09-07       Impact factor: 4.797

2.  Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis.

Authors:  Keita Ninagawa; Masaru Kato; Hiroyuki Nakamura; Nobuya Abe; Michihito Kono; Yuichiro Fujieda; Kenji Oku; Shinsuke Yasuda; Hiroshi Ohira; Ichizo Tsujino; Tatsuya Atsumi
Journal:  Rheumatol Int       Date:  2019-07-06       Impact factor: 2.631

Review 3.  Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment.

Authors:  Elisabetta Zanatta; Pamela Polito; Giulia Famoso; Maddalena Larosa; Elena De Zorzi; Elena Scarpieri; Franco Cozzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-22

Review 4.  Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.

Authors:  Akylbek Sydykov; Argen Mamazhakypov; Aleksandar Petrovic; Djuro Kosanovic; Akpay S Sarybaev; Norbert Weissmann; Hossein A Ghofrani; Ralph T Schermuly
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

5.  Text Mining-Based Drug Discovery for Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

Authors:  Jiang-Shan Tan; Song Hu; Ting-Ting Guo; Lu Hua; Xiao-Jian Wang
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

6.  Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension.

Authors:  Xingbei Dong; Yue Shi; Ying Xia; Xiao Zhang; Junyan Qian; Jiuliang Zhao; Jinmin Peng; Qian Wang; Li Weng; Mengtao Li; Bin Du; Xiaofeng Zeng
Journal:  BMC Pulm Med       Date:  2022-08-01       Impact factor: 3.320

7.  Diagnostic and prognostic value of ventilatory power in pulmonary hypertension.

Authors:  Xin Li; Yi Zhang; Qi Jin; Zhihui Zhao; Qing Zhao; Lu Yan; Anqi Duan; Zhihua Huang; Meixi Hu; Changming Xiong; Qin Luo; Zhihong Liu
Journal:  Respir Res       Date:  2022-10-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.